Pharmacological inhibition studies showed that the YAP1 silencing-mediated increase in TAZ expression may occur at the level of protein expression, although the increase could also result from the increase in TAZ mRNA expression as observed in YAP1-depleted xenografted tumors and one esophageal cancer line. The gene discussed is YAP1; the disease is esophageal cancer.